Amlodipine 5 mg + Atenolol 50 mg (Tab)
Brand Name: YASMLOTEN-AT
Amlodipine 5 mg + Atenolol 50 mg (Tab)
Product Overview
- YASMOLTEN-AT is a fixed-dose dual cardiovascular formulation combining Amlodipine 5 mg and Atenolol 50 mg. Amlodipine, a dihydropyridine L-type calcium channel blocker, inhibits calcium influx into vascular smooth muscle cells to induce peripheral arterial vasodilation. Atenolol selectively blocks beta-1 cardiac receptors, blunting sympathetic stimulation to reduce myocardial contractility, decrease resting heart rate, and lower myocardial oxygen demand.
- Designed to relieve an overworked heart, this two-in-one medication addresses high blood pressure from two angles. It relaxes tight blood vessel walls throughout the body while slowing down a fast or forceful heart rate, allowing the heart to pump blood with far less effort.
- Developed under stringent quality standards, YASMOLTEN-AT ensures consistent efficacy, safety, and patient compliance — empowering physicians to achieve optimal therapeutic outcomes in Hypertension Co-existing with Angina or Tachycardia.
Therapeutic Benefits / Key Features
- Dual-action therapy providing vasodilation and heart rate regulation.
- Ensures consistent blood pressure control throughout the day.
- Reduces cardiac workload and risk of angina episodes.
- Enhanced compliance through a convenient once-daily dose.
Brand Composition
Each film-coated tablet contains:
- Amlodipine Besylate equivalent to Amlodipine I.P. 5 mg
- Atenolol I.P. 50 mg
Why this formulation matters
- Ideal for patients requiring combination therapy for hypertension or angina.
- Demonstrates additive efficacy with reduced incidence of side effects.
- Supports long-term cardiovascular protection and stable heart rate control.
- Trusted and clinically proven combination with an established safety record.
Division Identity
Part of Yaselle Cardiora – Cardiac & Hypertension Care Division
Protecting every heartbeat with science and care.